bioRxiv · 10.1101/2024.12.20.629622
Antiviral activity of Tecovirimat against Mpox virus clades 1a, 1b, 2a and 2b
Abstract
The recent Mpox virus (MPXV) outbreak was caused by a novel and more pathogenic clade 1b virus. We compared the antiviral efficacy of Tecovirimat in cell culture, against the two ancestral clades 1a and 2a, the clade 2b that circulated in 2022, and the recent clade 1b virus. We report that Tecovirimat similarly inhibits the replication of all four MPXV clades, at nanomolar concentrations (nM). Our results suggest that Tecovirimat remains a therapeutic option against the latest clade 1b virus.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Postal, J., Guivel-Benhassine, F., Porrot, F., Grassin, Q., Crook, J., Vernuccio, R., Caro, V., Vanhomwegen, J., Guardado-Calvo, P., Simon-Loriere, E., Dacheux, L., Manuguerra, J.-C., Schwartz, O.. 2024-12-23. Antiviral activity of Tecovirimat against Mpox virus clades 1a, 1b, 2a and 2b. https://doi.org/10.1101/2024.12.20.629622
Cite the original work for its findings. Save a collection to share your selection of sources.